129 related articles for article (PubMed ID: 6055347)
21. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
22. [Westphal-Strumpell disease. Description of a clinical case].
Nuccetelli F; Assetta M; Colangelo U; Gambi D
Minerva Med; 1987 Sep; 78(17):1321-3. PubMed ID: 3670684
[TBL] [Abstract][Full Text] [Related]
23. Some therapeutic observations in Wilson's disease.
Shoulson I; Goldblatt D; Plassche W; Wilson G
Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
[No Abstract] [Full Text] [Related]
24. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
25. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
26. Copper toxicity, rats and Wilson's disease.
Nutr Rev; 1975 Feb; 33(2):51-3. PubMed ID: 1124157
[No Abstract] [Full Text] [Related]
27. Some problems of the penicillamine action in hepatolenticular degeneration.
Chromy K; Heyrovsky A
Metabolism; 1966 Jun; 15(6):529-36. PubMed ID: 5933915
[No Abstract] [Full Text] [Related]
28. Oral zinc therapy for Wilson's disease.
Nutr Rev; 1984 May; 42(5):184-6. PubMed ID: 6377131
[No Abstract] [Full Text] [Related]
29. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
BOUDIN G; PEPIN B
Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
[No Abstract] [Full Text] [Related]
30. [Copper metabolism: ultimate therapeutic implications in cholestasis].
Thierman-Duffaud D; Lévy VG
Med Chir Dig; 1981; 10(4):331-2. PubMed ID: 7300488
[No Abstract] [Full Text] [Related]
31. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
[No Abstract] [Full Text] [Related]
32. Gastrointestinal absorption of copper: studies with 64Cu, 95Zr, a whole-body counter and the scintillation camera.
Weber PM; O'Reilly S; Pollycove M; Shipley L
J Nucl Med; 1969 Sep; 10(9):591-6. PubMed ID: 5797847
[No Abstract] [Full Text] [Related]
33. Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens.
Hamlyn AN; Gollan JL; Douglas AP; Sherlock S
Br Med J; 1977 Sep; 2(6088):660-3. PubMed ID: 902043
[TBL] [Abstract][Full Text] [Related]
34. Copper and liver disease.
Eapen CE; Kumar S; Fleming JJ; Ramakrishna B; Abraham L; Ramachandran J
Gut; 2012 Jan; 61(1):63. PubMed ID: 22139599
[No Abstract] [Full Text] [Related]
35. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
[No Abstract] [Full Text] [Related]
36. [New views on the etiology, diagnosis and therapy of Wilson's disease].
Linke A
Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428
[No Abstract] [Full Text] [Related]
37. [Current treatment of hepatolenticular degenerescence].
Faur A; Păsculescu G; Dörl F
Med Interna (Bucur); 1972 Dec; 24(12):1413-9. PubMed ID: 4632206
[No Abstract] [Full Text] [Related]
38. The story of penicillamine: a difficult birth.
Walshe JM
Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
[No Abstract] [Full Text] [Related]
39. Juvenile Wilson disease: unusual features in three cases.
Jaeken J; Proesmans W
Acta Paediatr Belg; 1977; 30(2):91-6. PubMed ID: 888700
[No Abstract] [Full Text] [Related]
40. Metabolism of copper in hepatolenticular degeneration.
ZIMDAHL WT; HYMAN I; COOK ED
Neurology; 1953 Aug; 3(8):569-76. PubMed ID: 13087576
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
